Who requires longer-term anticoagulation therapy for venous thromboembolism from the perspective of precision medicine?

Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):270-271. doi: 10.1093/ehjcvp/pvae031.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anticoagulants* / administration & dosage
  • Anticoagulants* / adverse effects
  • Anticoagulants* / therapeutic use
  • Blood Coagulation / drug effects
  • Clinical Decision-Making
  • Drug Administration Schedule
  • Hemorrhage / chemically induced
  • Humans
  • Patient Selection
  • Precision Medicine*
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Venous Thromboembolism* / diagnosis
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / prevention & control

Substances

  • Anticoagulants